Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 16, 2023, titled “Glenmark receives acceptance from U.S. FDA on its IND application for GRC 54276 toproceed with……
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
